CVT-427: Phase I data

An open-label, intra-patient, U.S. Phase I trial in 21 healthy volunteers showed that inhaled CVT-427 had

Read the full 168 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE